Symptoms
Common signs and symptoms of Pulmonary Coccidioidomycosis include:
When to see a doctor
If you experience severe or worsening symptoms, seek immediate medical attention. Always consult with a healthcare professional for proper diagnosis and treatment.
Causes & Risk Factors
Several factors can contribute to Pulmonary Coccidioidomycosis.
Valley Fever results from infection with Coccidioides immitis or Coccidioides posadasii, two closely related fungal species that live in soil throughout the southwestern United States.
Valley Fever results from infection with Coccidioides immitis or Coccidioides posadasii, two closely related fungal species that live in soil throughout the southwestern United States. These fungi exist as mold in the ground, forming long filaments that break apart into microscopic spores when soil gets disturbed. The spores become airborne easily, traveling considerable distances on wind currents.
People contract the infection by breathing in these airborne spores.
People contract the infection by breathing in these airborne spores. Construction work, archaeological digs, military training exercises, and agricultural activities create high-risk scenarios for exposure. Even natural events like dust storms, earthquakes, or strong winds can lift spores into the air and spread them across wide areas. The fungi thrive in arid and semi-arid regions with alkaline soil, hot summers, and mild winters.
Once inhaled, the spores reach the lungs where they transform from their mold form into spherical structures called spherules.
Once inhaled, the spores reach the lungs where they transform from their mold form into spherical structures called spherules. These spherules grow and eventually burst, releasing hundreds of endospores that can spread the infection within the lungs or, in rare cases, to other parts of the body. The initial lung infection represents the body's first encounter with this unique pathogen, which explains why symptoms often resemble those of bacterial pneumonia or other respiratory infections.
Risk Factors
- Living in or traveling to endemic areas (Arizona, Central California, Nevada, New Mexico, Utah, Texas)
- Working in construction, archaeology, or agriculture
- Having a weakened immune system from HIV, cancer treatment, or organ transplant
- Being pregnant, especially in the third trimester
- Being of African American or Filipino descent
- Having diabetes or other chronic conditions
- Being over age 60
- Taking medications that suppress the immune system
- Participating in outdoor activities during dust storms
- Living in areas with recent construction or excavation
Diagnosis
How healthcare professionals diagnose Pulmonary Coccidioidomycosis:
- 1
Diagnosing Valley Fever often proves challenging because its symptoms closely mimic those of bacterial pneumonia, viral infections, or other respiratory conditions.
Diagnosing Valley Fever often proves challenging because its symptoms closely mimic those of bacterial pneumonia, viral infections, or other respiratory conditions. Many patients initially receive treatment for more common illnesses before doctors consider this fungal infection. Healthcare providers typically start with a detailed medical history, paying special attention to recent travel or residence in endemic areas.
- 2
Several laboratory tests can confirm Valley Fever diagnosis.
Several laboratory tests can confirm Valley Fever diagnosis. Blood tests can detect antibodies that the immune system produces in response to Coccidioides infection, though these antibodies may take several weeks to develop. Doctors also use antigen tests that identify fungal proteins directly in blood or urine samples. In some cases, they may examine sputum samples under a microscope to look for the characteristic spherules or attempt to grow the fungus in culture, though this process takes time and requires specialized laboratory facilities.
- 3
Chest X-rays and CT scans help evaluate lung involvement and rule out other conditions.
Chest X-rays and CT scans help evaluate lung involvement and rule out other conditions. These imaging studies may show pneumonia-like changes, lung nodules, or cavities in more severe cases. When doctors suspect disseminated disease, they may order additional tests including lumbar puncture for spinal fluid analysis, bone scans, or tissue biopsies from affected organs. Early diagnosis becomes especially important for high-risk patients who face greater chances of developing severe complications.
Complications
- Most people who develop Valley Fever recover completely without lasting effects, but some face serious complications that require ongoing medical care.
- Chronic pulmonary coccidioidomycosis can develop when the initial infection fails to clear completely, leading to persistent cough, chest pain, and fatigue that may last for years.
- Some patients develop lung nodules or cavities that can become secondarily infected with bacteria or cause persistent symptoms.
- Disseminated coccidioidomycosis represents the most serious complication, occurring in less than 5% of cases but carrying significant health risks.
- In this form, the infection spreads beyond the lungs to other organs including the brain, bones, joints, or skin.
- Meningitis, though rare, poses particular danger and requires aggressive treatment with long-term antifungal therapy.
- People with weakened immune systems, pregnant women, and individuals of certain ethnic backgrounds face higher risks for these severe complications.
Prevention
- Preventing Valley Fever focuses primarily on reducing exposure to contaminated dust and soil in endemic areas.
- While complete avoidance may not be practical for residents of affected regions, several strategies can significantly lower infection risk.
- During dust storms or windy conditions, people should stay indoors with windows and doors closed, and avoid outdoor activities that might increase dust exposure.
- For those working in high-risk occupations, proper protective equipment becomes essential.
- This includes wearing N95 respirators or higher-grade masks during construction, excavation, or agricultural work in endemic areas.
- Wetting down soil before disturbing it can help reduce the amount of dust that becomes airborne.
- Employers in affected regions should provide appropriate respiratory protection and educate workers about Valley Fever risks.
- Currently, no vaccine exists for Valley Fever, though researchers continue working toward this goal.
- People at high risk for severe complications should discuss prevention strategies with their healthcare providers, especially before traveling to endemic areas or engaging in high-risk activities.
- Some experts recommend that immunocompromised individuals consider avoiding non-essential travel to areas with high infection rates during peak transmission seasons, typically late summer and fall.
Treatment for Valley Fever varies significantly depending on the severity of symptoms and the patient's overall health status.
Treatment for Valley Fever varies significantly depending on the severity of symptoms and the patient's overall health status. Many people with mild symptoms require no specific antifungal medication, as their immune systems successfully clear the infection naturally over several months. During this period, doctors typically recommend rest, adequate hydration, and over-the-counter pain relievers for symptom management.
For patients with moderate to severe symptoms, or those at high risk for complications, antifungal medications become necessary.
For patients with moderate to severe symptoms, or those at high risk for complications, antifungal medications become necessary. Fluconazole represents the most commonly prescribed treatment, usually taken for 3-6 months or sometimes longer. Itraconazole serves as an alternative for patients who cannot tolerate fluconazole. These medications generally work well but can cause side effects including nausea, liver function changes, and drug interactions that require careful monitoring.
Severe cases or disseminated infections may require hospitalization and treatment with more potent antifungal drugs like amphotericin B, administered intravenously.
Severe cases or disseminated infections may require hospitalization and treatment with more potent antifungal drugs like amphotericin B, administered intravenously. This medication can cause significant side effects but remains essential for life-threatening infections. Patients with lung cavities may need surgical intervention if the cavities become large, infected with bacteria, or cause persistent symptoms.
Recent research has explored new treatment approaches, including combination antifungal therapy and immunomodulatory treatments that help boost the body's natural defenses.
Recent research has explored new treatment approaches, including combination antifungal therapy and immunomodulatory treatments that help boost the body's natural defenses. Clinical trials continue investigating novel antifungal agents that might offer improved effectiveness or fewer side effects than current options. Long-term monitoring remains important even after successful treatment, as some patients experience recurrent symptoms or develop chronic forms of the disease.
Living With Pulmonary Coccidioidomycosis
Managing life with Valley Fever requires patience and realistic expectations about recovery time. Many people find that fatigue and weakness persist for months even after other symptoms improve, making it important to pace activities and get adequate rest. Gradual return to normal activity levels works better than trying to resume full schedules too quickly.
Latest Medical Developments
Latest medical developments are being researched.
Frequently Asked Questions
Update History
Apr 27, 2026v1.0.0
- Published by DiseaseDirectory